Guozhen Ma#, Ruiying Liu#, Xueping Li#, Jialin Wu#, Yuanyuan Niu, Sheng Wang, Ziwei Chen, Xudong Qin, Qian Wang, Junyue Wang, Jiamin Qian, Mingqing Zhang, Yu Pang, Yamin Sun*, Guosheng Tang*, Tao Wang*, Yutao Liu*. Engineered Bacteria Enable Dual-Mechanism Therapy for 2 Enterohemorrhagic E. coli Infection via Carbon Source Competition 3 and Virulence Gene Silencing. Nature Communications. (2026). Doi:10.1038/s41467-026-69126-4.
点击次数:
上一条:Xueping Li, Yu Pang, Zixiang Liu, Jianwei Mu, Sheng Wang, Ziwei Chen, Zhiyun Wang*, Tao Wang*. Two-component system HprS/HprR enhances kidney colonization of uropathogenic Escherichia coli CFT073 by increasing flagellar expression. Cell Report. Volume 45, Issue 2, 24 February 2026, 116932. Doi: 10.1016/j.celrep.2026.116932.
下一条:Wenchang Peng#, Yajing Du#, Luna Cui1#, Yi Xiao, Lavonda Li, Lijie Yan , Yun Gu, Lulu Zhang, Bowen Li, Zhiyun Wang, Hua Wang, Xinyu Dai, Yue Teng *, Tao Wang*, Bin Zheng* and Xingcai Zhang*. Bioorthogonal Optimized Virus Immuno-Nanomedicine (BOVIN). Nature Communications. 5 November 2025. Doi: 10.1038/s41467-025-66089-w
